We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly, BMS Stop Enrollment for Phase III Lung Cancer Study
Lilly, BMS Stop Enrollment for Phase III Lung Cancer Study
February 16, 2011
Eli Lilly and Bristol-Myers Squibb (BMS) said Feb. 3 they will enroll no new patients in a Phase III lung cancer trial of necitumumab after some patients developed blood clots.